{
    "title": "Scientists turn to aspirin to turbo-charge cancer immunotherapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3221271/Scientists-turn-aspirin-turbo-charge-cancer-immunotherapy.html",
    "date": "2015-09-03",
    "keywords": [
        "cancer",
        "immunotherapy",
        "aspirin",
        "treatment",
        "gmt",
        "september",
        "response",
        "bowel",
        "mice",
        "way",
        "email",
        "ben",
        "hirschlerlondon",
        "effectiveness",
        "care",
        "longerlasting",
        "side",
        "casesone",
        "reason",
        "molecule",
        "prostaglandin",
        "e2",
        "pge2",
        "crick",
        "instituteaspirin",
        "production",
        "growth",
        "melanoma",
        "evidence",
        "tissue",
        "research",
        "reputation",
        "drug",
        "chemist",
        "bayer",
        "century",
        "medicine",
        "heart",
        "risk",
        "cancerscaetano",
        "group",
        "leader",
        "institute",
        "inhibitor",
        "day",
        "difference",
        "trial",
        "company",
        "conversationsmerck",
        "development",
        "roche",
        "journal",
        "cell",
        "thursday",
        "antipd1",
        "e",
        "sousa",
        "effect",
        "pd1",
        "pdl1",
        "class",
        "ctla4with",
        "future",
        "use",
        "mix",
        "lid",
        "greg",
        "mahlich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}